scispace - formally typeset
Open AccessJournal ArticleDOI

Quality of life of people living with HIV and AIDS and antiretroviral therapy

TLDR
The development of antiretroviral drugs has significantly changed the perception of HIV/AIDS from a very fatal to a chronic and potentially manageable disease, and the availability and administration of ART has significantly reduced mortality and morbidity associated with HIV and AIDS.
Abstract
The development of antiretroviral drugs has significantly changed the perception of HIV/AIDS from a very fatal to a chronic and potentially manageable disease, and the availability and administration of antiretroviral therapy (ART) has significantly reduced mortality and morbidity associated with HIV and AIDS. There is a relationship between ART and quality of life of people living with HIV and AIDS, and several studies have reported a strong positive association between ART and improved quality of life in different domains among people living with HIV and AIDS in both developed and developing countries. However, a few studies have reported on the negative effects of ART, which directly or indirectly relate to the quality of life and longevity of HIV-infected persons. In this review, the effects and benefits of ART on people living with HIV and AIDS based on studies done in developed and developing countries is examined.

read more

Citations
More filters
Journal ArticleDOI

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

TL;DR: Cardiovascular risk among HIV infected patients, interventions on behavior and lifestyles, use of drugs to reduce the risk, and switch in antiretroviral therapy, remain nowadays major issues in the management of HIV-infected patients.
Journal ArticleDOI

Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection

TL;DR: There were modest but significant improvements in self-assessed QOL among those initiating ART immediately compared to deferring treatment, supporting patient-perceived health benefits of initiating ART as soon as possible after an HIV diagnosis.
Journal ArticleDOI

Effects of Combined Aerobic and Resistance Exercise on Exercise Capacity, Muscle Strength and Quality of Life in HIV-Infected Patients: A Systematic Review and Meta-Analysis.

TL;DR: Combined aerobic and resistance exercise may improve peak VO2, muscle strength and health status, energy and physical function domains of quality of life and should be considered as a component of care of HIV-infected individuals.
References
More filters
Journal ArticleDOI

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

TL;DR: Given the critical importance of adherence to therapy to patient outcome, secondary prevention of HIV infection, and willingness of providers to prescribe therapy, this prospectively investigated the association between protease inhibitor adherence and patient outcome and factors related to adherence.
Journal ArticleDOI

Combination antiretroviral therapy and the risk of myocardial infarction

TL;DR: Combination antiretroviral therapy was independently associated with a 26 percent relative increase in the rate of myocardial infarction per year of exposure during the first four to six years of use, however, the absolute risk of my Cardiac Infarction was low and must be balanced against the marked benefits from antireTroviral treatment.
Journal ArticleDOI

Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress

TL;DR: Howglutathione biosynthesis, glutathione peroxidases, glutATHione S-transferases and glutathion S-conjugate efflux pumps function in an integrated fashion to allow cellular adaption to oxidative stress is discussed.
Journal ArticleDOI

Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy

TL;DR: The data demonstrate uniformly low rates of disease progression to death and AIDS or death among patients starting antiretroviral therapy with CD4 cell counts of at least 200/microL, as well as a prior diagnosis of acquired immunodeficiency syndrome (AIDS).
Related Papers (5)